Cannara Biotech GAAP EPS of $0.01, revenue of $30.1M
Source: SeekingAlpha
2026-01-26 09:49:03 ET
More on Cannara Biotech Inc.
- Cannara Biotech GAAP EPS of C$0.04, revenue of C$28.3M
- Seeking Alpha’s Quant Rating on Cannara Biotech Inc.
- Historical earnings data for Cannara Biotech Inc.
- Financial information for Cannara Biotech Inc.
Read the full article on Seeking Alpha
For further details see:
Cannara Biotech GAAP EPS of $0.01, revenue of $30.1M
Cannara Biotech Inc
NASDAQ: LOVFF
LOVFF Trading
0.76% G/L:
$1.32 Last:
2,240 Volume:
$1.33 Open:
LOVFF Latest News
February 04, 2026 08:00:00 am
Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced at C$2.10 per Common Share
